Search
× Search

Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea (OSA) is a condition where the airway narrows during sleep causing brief episodes of stopping breathing and lack of restful sleep.

The main symptoms of OSA are:

  • Loud snoring
  • Episodes of stopping breathing during sleep
  • Waking up at night gasping for air
  • Restless sleep
  • Morning headaches
  • Feeling tired or groggy throughout the day

Some things that make obstructive sleep apnea worse are being overweight, sleeping on one’s back and drinking alcohol before bed.

The diagnosis of OSA is by a sleep study where breathing patterns at night are monitored and evaluated.

If OSA is found, there are several treatment options including weight loss, continuous positive airway pressure devices (CPAP) that are used at night, mouth/oral appliances and even surgery in some cases.

Please talk to your provider if you are concerned that you may have OSA.

Recent News

SuperUser Account
/ Categories: News

CDC approves monovalent COVID-19 boosters for adults

On October 24, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.

This action gives people ages 18 years and older the option to receive a Novavax monovalent booster instead of an updated (bivalent) Pfizer-BioNTech or Moderna booster if they have completed primary series vaccination but have not previously received a COVID-19 booster-;and if they cannot or will not receive mRNA vaccines.

Some may be unable to receive an mRNA vaccine as a result of an allergy to a component of an mRNA COVID-19 vaccine, or as a result of a history of a severe allergic reaction (such as anaphylaxis) after a previous dose of an mRNA COVID-19 vaccine, or a lack of availability of an mRNA vaccine. People ages 18 and older may also choose to receive a Novavax monovalent booster if they are unwilling to receive mRNA vaccines, and would otherwise not receive a booster dose.

FDA’s authorization of monovalent COVID-19 boosters and CDC’s recommendation for use, are important steps forward in our country’s comprehensive vaccination program-;a program that has helped provide increased protection for all Americans against COVID-19 disease and death.

Any questions, talk to your OAAC provider.

The post CDC approves monovalent COVID-19 boosters for adults appeared first on Oklahoma Allergy and Asthma Clinic.

Previous Article Allergies, Asthma and Winter Holidays
Next Article Study shows limited benefits of elimination diets for children with atopic dermatitis
Print
20
Terms Of UsePrivacy StatementCopyright 2026 by Oklahoma Allergy and Asthma Clinic
Back To Top